# V1 Empirics Check — openai/gpt-5.1-codex-mini (Variant A)

**Model:** openai/gpt-5.1-codex-mini
**Variant:** A
**Date:** 2026-03-24T15:31:09.521458

---

**Idea Fidelity**

The paper diverges from the original manifest in material ways. The proposed design relied on a Bartik (shift-share) IV taking baseline per-capita public health grant shares interacted with national grant changes as an instrument for stop smoking service spending. The manuscript instead estimates a continuous-treatment difference-in-differences using the 2015 baseline grant interacted with a post-2015 indicator. As a result, the “treatment” is interpreted as differential austerity exposure based on initial grant levels, rather than the quasi-experimental variation in annual grant shocks emphasized in the manifest. That change matters for both the causal interpretation (no shift-share exogeneity argument is ever made) and the empirical implementation (no first stage, no instrumented spending). Apart from that, the paper aligns with the manifest’s goals: it uses Fingertips data on quit rates, smoking prevalence, and COPD admissions; focuses on England’s stop smoking services; and emphasizes the policy relevance of austerity-induced service cuts. But the paper misses the key identification innovation promised in the manifest.

---

**Summary**

The paper studies how austerity-driven cuts to England’s public health grant affected stop smoking services across upper-tier local authorities. Using a continuous-treatment difference-in-differences, it finds that authorities with higher needs-based baseline grants maintained substantially higher CO-validated quit rates after 2015, even as smoking prevalence and COPD admissions data are subject to convergence dynamics. The finding is interpreted as evidence of “cessation capital” that depreciates slowly under fiscal pressure but quickly when services are shuttered (e.g., during COVID).

---

**Essential Points**

1. **Identification strategy needs stronger justification**  
   The key causal claim relies on comparing high- and low-grant authorities after 2015, but the paper never convincingly shows why baseline grant per capita interacted with a post indicator isolates the effect of austerity on cessation services. The manifest promised a Bartik-style instrument leveraging national grant cuts (shift) and grant shares (share); the current specification collapses that variation into a single difference-in-differences term. Without a clear source of quasi-exogenous variation—e.g., why authorities with higher baseline grants were not already on different post-2015 trajectories for reasons other than austerity—the interpretation is at risk. The convergence argument is persuasive for downstream prevalence, but the quit rate result could still reflect other correlated shocks (e.g., differential NHS integration, workforce retention, or local public health strategies). Please either implement the proposed Bartik IV (with first-stage diagnostics) or provide more extensive evidence that the baseline-grant-by-post comparison is exogenous beyond fixed effects and trends.

2. **Limited pre-treatment variation for primary outcome weakens parallel trends**  
   The CO-validated quit rate series exists only from 2013/14, so the event study effectively has a single pre-period. This makes it impossible to test the parallel trends assumption with any power. While the reported 2013 estimate is near zero, that is to be expected with only one pre-treatment year. To draw causal inference, the authors need either to extend the pretreatment window (if earlier data exist) or to provide supplementary evidence that the quit rate differential was not already evolving by exploiting other data (e.g., voucher or referral counts, budget allocations for cessation services, media campaigns) that would reflect pre-2015 trends.

3. **Mechanism and mediation remain speculative**  
   The “cessation capital” interpretation hinges on the idea that organizational stocks persisted despite cuts, yet the paper never measures these stocks directly. Without data on counselor staffing, outreach networks, or referral volumes, the interpretation remains narrative. Moreover, the fact that authority-level quit rates were higher for high-grant areas even before austerity (see Table 1) suggests persistent differences in service scale. The analysis should either incorporate direct measures of cessation service inputs or at least show that the quit rate gap widened only after 2015 (beyond the event study already provided) and that other contemporaneous policies could not explain it.

---

**Suggestions**

1. **Revisit the identification strategy in light of the manifest and available data**  
   - If the Bartik IV is still feasible, construct it explicitly: regress stop smoking service spending (or quit rates) on the interaction of baseline grant shares with national grant changes, include authority and year fixed effects, and present first-stage diagnostics (F-statistics, coefficient magnitude). This would align the paper with the manifest and provide a clearer exogenous shock to service capacity.  
   - Alternatively, if the Bartik is infeasible (e.g., because service-specific spending data are unavailable), be explicit that the treatment is a proxy for fiscal pressure and motivate why differential exposure to austerity is as good as random once you include authority fixed effects and common trends. This could involve showing that other observable pre-2015 characteristics (demographics, economic conditions, political control) do not predict the post-2015 quit rate differential after conditioning on grant levels.  
   - Consider augmenting the specification with time-varying controls for other local austerity-related shocks (e.g., changes in adult social care spending, NHS trust reorganizations) that might correlate with baseline grant intensity.

2. **Strengthen the parallel trends evidence for quit rates**  
   - Look for additional pre-2015 information that proxy for cessation activity: e.g., published stop smoking service plans, recorded quit attempts, or even related indicators like prescribing volumes of nicotine replacement therapy. Even if these data are sparse, including them could bolster the claim that high- and low-grant areas were on similar trajectories before austerity.  
   - If additional pre-treatment years cannot be obtained, consider a synthetic control approach where each high-grant authority is compared to a weighted combination of low-grant authorities matched on pre-2015 covariates. This would provide a robustness check on the parallel trends assumption.  
   - Use placebo cut-off years (e.g., pretending austerity began in 2011) to show that the identified effect only emerges when the actual policy change occurs.

3. **Clarify the mechanism behind “cessation capital”**  
   - Incorporate any available data on stop smoking service inputs (e.g., number of counselors, pharmacy partnerships, budget shares) to show that these inputs were indeed more persistent in high-grant authorities.  
   - If direct input data are unavailable, include qualitative or administrative evidence that high-grant authorities tended to protect cessation services (e.g., from LA spending reports or minutes) so that the observed quit rate persistence is plausibly due to organizational capital rather than other factors.  
   - Alternatively, decompose the quit rate effect into components such as service reach (number of clients) versus effectiveness (success rate) if the data allow; this would help distinguish between stock versus flow explanations.

4. **Expand the placebo analysis**  
   - The placebo on chlamydia screening is helpful, but sexual health services may have faced their own cut dynamics. Consider additional falsification exercises: for example, outcomes in areas of public health not expected to be closely tied to smoking services (e.g., childhood obesity programs, health visiting) or even unrelated municipal services if data exist.  
   - Another idea is to look at quit rates for subpopulations less dependent on local services (e.g., heavier smokers who receive NHS support) as a placebo outcome; no effect in these groups would strengthen the causal story.

5. **Report effect sizes in more policy-relevant terms**  
   - The main coefficient of ~173 quits per 100,000 per SD of baseline grant is informative, but policymakers might benefit from translating this into the share of total quits preserved, or the implied increase in quitters per pound of protected grant.  
   - Provide back-of-the-envelope calculations linking the estimated quit rate effect to long-run health outcomes (COPD hospitalizations avoided, life-years gained) using established estimates from the cessation literature. This would highlight the broader public health stakes and connect the quit rate findings to morbidity/mortality arguments.

6. **Address concerns about sample attrition and measurement**  
   - The quit rate panel loses a few authorities due to data gaps; clarify whether these dropouts are random or related to austerity (e.g., authorities that completely shut services might stop reporting quits). If non-random, this could bias the estimates upward.  
   - Ensure that the measurement of baseline grant per head is not mechanically correlated with population size or other variables that might drive quit rates. If necessary, include population controls or interact baseline grant with size to show robustness.

7. **Consider heterogeneity analyses**  
   - Explore whether the quit-rate effect varies by deprivation, urban/rural status, or political control. If the “cessation capital” story holds, we might expect more persistence in areas where services were previously well-established (e.g., urban, high-deprivation).  
   - Similarly, test whether the effect is larger in authorities that had historically stronger stop smoking services (e.g., high quit rates or budgets before austerity). This would provide direct evidence that the effect is driven by service capacity.

By addressing these points, the paper would present a firmer causal claim and a richer narrative about how austerity interacts with public health investment.
